Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions

March 4, 2021 updated by: Rajani Sadasivam, University of Massachusetts, Worcester

Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco

The research study, "Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions" will test two smoker-driven, social marketing innovations to recruit and engage smokers in Decide2Quit.org (Decide2Quit), which is an evidence-based, effective "Digital Intervention for Smoking Cessation".

Study Overview

Detailed Description

S2S has many innovations that are designed to utilize the power of peers and social networks for dissemination. These include: Peer recruitment: Tools to facilitate smokers' recruiting their peers to increase Decide2Quit access; and a recommender computer tailored health communication (recommender CTHC): a Complex machine learning algorithm (recommender systems) that uses smokers' feedback (explicit and implicit) in the current and prior studies to adapt its selection of messages to smokers.

Using a 2×2 factorial design, the study will compare individually and collectively the enhancements (recruitment, use, and effectiveness) offered by the S2S functions over the standard version of Decide2Quit (online recruitment and standard CTHC), an active comparison group.

Study Type

Interventional

Enrollment (Actual)

1487

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Worcester, Massachusetts, United States, 01605
        • University of Massachusetts Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of Age or older
  • Current smoker

Exclusion Criteria:

  • Under 18 years of age
  • Non-smoker

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fully enhanced
Peer recruitment and recommender CTHC
Enhanced Messaging
Tools to facilitate smokers' recruiting their peers
Experimental: Recommender CTHC only
Recommender CTHC and standard online recruitment
Enhanced Messaging
Search Engine and Social Media Advertisements
Experimental: Peer recruitment only
Peer recruitment and standard CTHC
Tools to facilitate smokers' recruiting their peers
Standard Messaging
Experimental: Standard
Standard online recruitment and standard CTHC
Search Engine and Social Media Advertisements
Standard Messaging

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Smoking Cessation
Time Frame: At 6 months post registration

Smoking cessation measured by the 7-day point prevalence question:

Six month, 7-day point prevalence : Do you currently smoke cigarettes (smoked even 1 puff in the last 7 days)?

  • Yes
  • No
  • Don't know/not sure
  • Refused
At 6 months post registration

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the Number of Cigarettes Smoked
Time Frame: At 6 months post registration
Calculated as: number of cigarettes smoked at six months minus the number of number of cigarettes smoked at baseline.
At 6 months post registration
Repeated Use of Decide2Quit Functions
Time Frame: Throughout study (tracked for 6 months post registration)
As measured by, an ordinal scale of number of Decide2Quit functions used after the first DISC visit (0: no functions used; 1: use of 1-2 functions, 2: > 2 functions used).
Throughout study (tracked for 6 months post registration)
Recruitment of African Americans
Time Frame: At Baseline Registration
This is measured by the proportion of African Americans in each treatment arm
At Baseline Registration
Recruitment Time
Time Frame: At Baseline Registration
Calculated as: each individual participant's recruitment date minus the date of the first participant's registration. Based on this formula, the first participant will have a recruitment time of 0 days and the last participant could have a maximum recruitment time of 3 years (1095 days).
At Baseline Registration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Rajani Sadasivam, PhD, University of Massachusetts, Worcester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 20, 2017

Primary Completion (Actual)

November 1, 2019

Study Completion (Actual)

March 13, 2020

Study Registration Dates

First Submitted

June 21, 2017

First Submitted That Met QC Criteria

July 18, 2017

First Posted (Actual)

July 21, 2017

Study Record Updates

Last Update Posted (Actual)

March 26, 2021

Last Update Submitted That Met QC Criteria

March 4, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CDR-1603-34645
  • CDR160334645 (Other Grant/Funding Number: Patient-Centered Outcomes Research Institute)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Recommender CTHC

Subscribe